Evidence map›Paper›PMID 22918415›Full record

ReviewNature reviews. Cancer2012

Aiding and abetting roles of NOX oxidases in cellular transformation.

Karen Block, Yves Gorin

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 162 papers.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

162 citing papers in PubMed, 287 citations in OpenAlex.

  1. Review
  2. ROS and Antioxidants: Prospective Therapeutic Options in Cancer.Journal of cellular and molecular medicine · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. The Role of Redox Environment in Tumors.Current medicinal chemistry · 2025
    Review
  19. Review
  20. Review

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Karen BlockSouth Texas Veterans Health Care System, Audie L. Murphy Memorial Hospital Division, Department of Medicine, San Antonio, Texas 78229-73900, USA. block@uthscsa.edu
Yves Gorin
South Texas Veterans Health Care System · USThe University of Texas Health Science Center at San Antonio · US

Funding

Mechanism of eNOS Uncoupling in the Renal MicrovasculatureR01DK079996 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GORIN, YVES CLAUDE · 2010 to 2014
$1.5M
Mechanisms of Renal CarcinogenesisR01CA131272 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BLOCK, KAREN · 2008 to 2011
$907k
NCI NIH HHS CA131272NCI NIH HHS R01 CA131272NIDDK NIH HHS R01 DK079996
6 · The paper itself

Abstract

NADPH oxidases of the NADPH oxidase (NOX) family are dedicated reactive oxygen species-generating enzymes that broadly and specifically regulate redox-sensitive signalling pathways that are involved in cancer development and progression. They act at specific cellular membranes and microdomains through the activation of oncogenes and the inactivation of tumour suppressor proteins. In this Review, we discuss primary targets and redox-linked signalling systems that are influenced by NOX-derived ROS, and the biological role of NOX oxidases in the aetiology of cancer.

Indexed as

Cell Transformation, NeoplasticHumansNADPH OxidasesNeoplasmsOxidative StressReactive Oxygen SpeciesSignal TransductionNADPH OxidasesReactive Oxygen Species

Identifiers

PMID22918415
PMCPMC3711509
OpenAlexW1993552192

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.